2009年甲型H1N1流感大流行疫苗有效性:系统综述与Meta分析
该系统综述与Meta分析检索2009年6月11日至2014年11月12日数据库及灰色文献,纳入38项中等偏倚风险研究(23项可合并),评估单价甲型H1N1pdm09疫苗对实验室确诊流感及住院的有效性。含佐剂疫苗对实验室确诊流感的合并调整疫苗有效性为80%(95%CI 59-90%),无佐剂疫苗为66%(95%CI 47-78%);对住院的合并调整疫苗有效性为61%(95%CI 14-82%)。含佐剂与无佐剂疫苗均能预防实验室确诊流感,总体对流感相关住院亦有效;两种结局下含佐剂疫苗在儿童中比成人更有效。
要点
- 含佐剂疫苗对实验室确诊流感的合并调整VE为80%(95%CI 59-90%)。
- 无佐剂疫苗对实验室确诊流感的合并调整VE为66%(95%CI 47-78%)。
- 对住院的合并调整VE为61%(95%CI 14-82%);含佐剂疫苗在儿童中比成人更有效。
核心结论
- 含佐剂与无佐剂单价甲型H1N1pdm09疫苗均能有效预防实验室确诊流感,总体对流感相关住院亦有效;两种结局下含佐剂疫苗在儿童中比成人更有效。
研究设计与样本
- 系统综述与Meta分析,检索2009年6月11日至2014年11月12日的医疗数据库及灰色文献,纳入38项中等偏倚风险研究,其中23项适合Meta分析。
主要发现
- 含佐剂疫苗对实验室确诊流感的合并调整VE为80%(95%CI 59-90%),无佐剂疫苗为66%(95%CI 47-78%),均达统计学显著。
- 计划二次分析中,成人VE常未达统计学显著,合并点估计低于儿童中观察值。
- 对住院的总体合并调整VE为61%(95%CI 14-82%);计划二次分析中,含佐剂疫苗在18-64岁成人及儿童中调整VE达统计学显著。
- 两种结局下含佐剂疫苗在儿童中比成人更有效,差异有统计学意义。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: The clinical effectiveness of monovalent influenza A(H1N1)pdm09 vaccines has not been comprehensively summarised. We undertook a systematic review and meta-analysis to assess vaccine effectiveness (VE) for adjuvanted and unadjuvanted vaccines. METHODS: We searched healthcare databases and grey literature from 11 June 2009 to 12 November 2014. Two researchers independently assessed titles and abstracts to identify studies for full review. Random effects meta-analyses estimated the pooled effect size of vaccination compared to placebo or no vaccination for crude and adjusted odds ratios (OR) to prevent laboratory confirmed influenza illness (LCI) and related hospitalization. VE was calculated as (1-pooled OR)∗100. Narrative synthesis was undertaken where meta-analysis was not possible. RESULTS: We identified 9229 studies of which 38 at moderate risk of bias met protocol eligibility criteria; 23 were suitable for meta-analysis. Pooled adjusted VE against LCI with adjuvanted and unadjuvanted vaccines both reached statistical significance (adjuvanted: VE=80%; 95% confidence interval [CI] 59-90%; unadjuvanted: VE=66%; 95% CI 47-78%); in planned secondary analyses, VE in adults often failed to reach statistical significance and pooled point estimates were lower than observed in children. Overall pooled adjusted VE against hospitalization was 61% (95% CI 14-82%); in planned secondary analyses, adjusted VE attained statistical significance in adults aged 18-64years and children for adjuvanted vaccines. Adjuvanted vaccines were significantly more effective in children compared to adults for both outcomes. CONCLUSIONS: Adjuvanted and unadjuvanted monovalent influenza A(H1N1)pdm09 vaccines were both effective in preventing LCI. Overall, the vaccines were also effective against influenza-related hospitalization. For both outcomes adjuvanted vaccines were more effective in children than in adults.
引用
- Lansbury LE, Smith S, Beyer W, et al. Effectiveness of 2009 pandemic influenza A(H1N1) vaccines: A systematic review and meta-analysis. Vaccine. 2017. PMID: 28302409. doi:10.1016/j.vaccine.2017.02.059
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。